-+ 0.00%
-+ 0.00%
-+ 0.00%

CARIBOU BIOSCIENCES - EXPECTS $10 MLN-$11 MLN IN SEVERANCE, $5 MLN-$8 MLN FOR CLINICAL TRIAL WIND-DOWN - SEC FILING

Reuters·10/06/2026 20:09:56

Please log in to view news